The Enterprise Value as of September 2024 (TTM) for Virios Therapeutics, Inc. (VIRI) is 2.47M

According to Virios Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.47M. This represents a change of -68.61% compared to the average of 7.87M of the last 4 quarters.

Virios Therapeutics, Inc. (VIRI) Historical Enterprise Value (quarterly & annually)

How has VIRI Enterprise Value performed in the past?

The mean historical Enterprise Value of Virios Therapeutics, Inc. over the last ten years is 47.79M. The current 2.47M Enterprise Value has changed 416.94% with respect to the historical average. Over the past ten years (40 quarters), VIRI's Enterprise Value was at its highest in in the September 2020 quarter at 134.53M. The Enterprise Value was at its lowest in in the September 2022 quarter at -6283214.14.

Virios Therapeutics, Inc. (VIRI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Virios Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Virios Therapeutics, Inc. (VIRI) Average Enterprise Value

How has VIRI Enterprise Value performed in the past?

The current Enterprise Value of Virios Therapeutics, Inc. (VIRI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Virios Therapeutics, Inc. (VIRI) Enterprise Value vs. Peers

How is VIRI’s Enterprise Value compared to its peers?

Virios Therapeutics, Inc.’s Enterprise Value is less than SeaStar Medical Holding Corporation (22.08M), greater than ZyVersa Therapeutics, Inc. (2.43M), greater than Sonnet BioTherapeutics Holdings, Inc. (1.10M), greater than Revelation Biosciences, Inc. (-10577409.00), less than eFFECTOR Therapeutics, Inc. (3.86M), less than Zura Bio Limited (41.78M), greater than Navidea Biopharmaceuticals, Inc. (-2504975.00), less than Immix Biopharma, Inc. (27.90M), less than CNS Pharmaceuticals, Inc. (3.40M), greater than Altamira Therapeutics Ltd. (895.65K), greater than Phio Pharmaceuticals Corp. (-1904616.00), greater than TransCode Therapeutics, Inc. (1.38M),

Build a custom stock screener for Virios Therapeutics, Inc. (VIRI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Virios Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Virios Therapeutics, Inc. (VIRI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Virios Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.